Investigating the impact of open label design on patient‐reported outcome results in prostate cancer randomized controlled trials

BACKGROUND: While open‐label randomized controlled trials (RCT) are common in oncology, some concerns have been expressed with regard to Patient‐Reported Outcomes (PRO)‐based claims stemming from these studies. We aimed to investigate the impact of open‐label design in the context of prostate cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Mouillet, Guillaume, Efficace, Fabio, Thiery‐Vuillemin, Antoine, Charton, Emilie, Van Hemelrijck, Mieke, Sparano, Francesco, Anota, Amélie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571808/
https://www.ncbi.nlm.nih.gov/pubmed/32846465
http://dx.doi.org/10.1002/cam4.3335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7571808/
https://www.ncbi.nlm.nih.gov/pubmed/32846465
http://dx.doi.org/10.1002/cam4.3335

Ejemplares similares